Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12471536 | 0.75 | LMNA (0.36) | THRB | |
| SCHEMBL20599906 | 0.75 | PTPN1 (0.35) | — | |
| SCHEMBL7951950 | 0.72 | — | — | |
| SCHEMBL8940848 | 0.71 | GGT1 (0.35) | — | |
| SCHEMBL88810 | 0.69 | TSHR (0.32) | — | |
| SCHEMBL5128930 | 0.69 | — | — | |
| SCHEMBL23015998 | 0.68 | — | — | |
| SCHEMBL20459207 | 0.68 | LMNA (0.50) | — | |
| Hydrochloric Acid SCHEMBL7032035 | 0.68 | TSHR (0.30) | — | |
| SCHEMBL14405035 | 0.67 | LMNA (0.46) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1245249-A2 | Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug | Aventis Pasteur (FR) | 2002-10-02 | — | — | EP | disclosed |
| US-6124270-A | IMMUNOLOGY, GENE THERAPY | PASTEUR MERIEUX SERUMS ET VACCINS (FR) | 2000-09-26 | — | — | US | disclosed |
| EP-0769942-A1 | USE OF A CATIONIC AMPHIPATHIC COMPOUND AS A TRANSFECTION AGENT, VACCINE ADDITIVE OR DRUG | PASTEUR MERIEUX SERUMS ET VACCINS (FR) | 1997-05-02 | — | — | EP | disclosed |
| WO-1996032102-A1 | USE OF A CATIONIC AMPHIPATHIC COMPOUND AS A TRANSFECTION AGENT, VACCINE ADDITIVE OR DRUG | PASTEUR MERIEUX SERUMS ET VACCINS (FR) | 1996-10-17 | — | — | WO | disclosed |